Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

KalVista Pharmaceuticals (KALV) Interest & Investment Income: 2013-2025

Historic Interest & Investment Income for KalVista Pharmaceuticals (KALV) over the last 13 years, with Apr 2025 value amounting to $6.4 million.

  • KalVista Pharmaceuticals' Interest & Investment Income fell 10.31% to $1.4 million in Q2 2025 from the same period last year, while for Apr 2025 it was $5.2 million, marking a year-over-year increase of 78.92%. This contributed to the annual value of $6.4 million for FY2025, which is 65.17% up from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Interest & Investment Income stood at $6.4 million for FY2025, which was up 65.17% from $3.9 million recorded in FY2024.
  • KalVista Pharmaceuticals' 5-year Interest & Investment Income high stood at $6.4 million for FY2025, and its period low was $903,000 during FY2021.
  • Over the past 3 years, KalVista Pharmaceuticals' median Interest & Investment Income value was $3.9 million (recorded in 2024), while the average stood at $4.2 million.
  • Per our database at Business Quant, KalVista Pharmaceuticals' Interest & Investment Income slumped by 50.66% in 2021 and then spiked by 104.77% in 2023.
  • KalVista Pharmaceuticals' Interest & Investment Income (Yearly) stood at $903,000 in 2021, then grew by 20.71% to $1.1 million in 2022, then skyrocketed by 104.77% to $2.2 million in 2023, then soared by 74.55% to $3.9 million in 2024, then skyrocketed by 65.17% to $6.4 million in 2025.